NEW YORK (GenomeWeb News) – Co-Diagnostics and DNA Logix have created a joint venture to tackle infectious diseases in high-burden developing countries.

The venture, called Co-Diagnostics HBDC, will sell testing products and services based on PCR testing technology developed by DNA Logix to HBDCs. Co-Diagnostics HBDC is licensing the technology specifically for the HBDC market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.